1Wolff LJ , Lovfien EW. Management of fractures in hemophilia[ J ]. Pediatrics, 1982, 70(3) : 431-461. 被引量：1
2Redeghiero F, Castaman G, Bona ED, et al. Consistency of responses to repeated infusions in patients with yon Willebrand's disease and hemophilia A[J]. Blood , 1989, 74(6) :1997-2000. 被引量：1
3Kreuz W, Escufiola-Ettingshausen C, Martinez-Saguer I,et al. Epidemiology of inhibitor development in haemophilia A patients treated with virus-inactivated plasma-derived clotting factor concentrates [J]. Vox Sang,1999,77 (Suppl 1 ) :3-8. 被引量：1
4Kaw LLJ, Coimbra R, Potenza BM,et al. The use of recombinant factor VIIa for severe intractable bleeding during spine surgery[ J ]. Spine,2004,29( 12 ) : 1384-1387. 被引量：1
5Boardman KP, English P. Fractures and dislocations in hemoph/lia [J]. Clin Orhtop,1980,148(3) : 221-321. 被引量：1
5Kaw LL Jr, Coimbra R, Potenza BM, et al. The use of recombinant factor VII for severe intractable bleeding during spine surgery. Spine ( Phila Pa 1976 ) , 2004,29 ( 12 ) : 1384-1387 ; discussion 1388. 被引量：1
6Weiskopf RB. The use of recombinant activated coagulation factor VII for spine surgery. Eur Spine J, 2004,13 Suppl 1 :S83-88. 被引量：1
